 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Nomination & Remuneration Committee of Glenmark Pharmaceuticals Ltd, at its meeting held on February 02, 2017 has allotted 41,875 stock options and cancelled 20,938 stock options pursuant to Employee Stock Options Scheme, 2016.
The Options granted under Employee Stock Options Scheme, 2016 and exercise thereof is subject to all applicable laws.
Shares of GLENMARK PHARMACEUTICALS LTD. was last trading in BSE at Rs.947.3 as compared to the previous close of Rs. 907.95. The total number of shares traded during the day was 263094 in over 10192 trades.
The stock hit an intraday high of Rs. 970.25 and intraday low of 940.95. The net turnover during the day was Rs. 251150808.